Search results
-
Mr Oscar Baldwin
... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...
-
Dr Saif Ahmad
I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...
-
Dr Sujath Abbas
... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...
-
Professor Walid Khaled
... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...
-
Dr David Gilligan
David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...
-
Mr David Thurtle
Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer
-
Dr Roisin Owens
Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...
-
Mr Thierry Lefebvre
Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...
-
Mr Adam Palmer
-
Dr Avgi Andreou
-
Dr Alexander Azizi
-
Miss Ariella Stewart
-
Mrs Abigail Redman
-
Dr Anita Chandra
-
Dr Aideen Daly
-
Dr Andrea Degasperi
-
Miss Aristi Damaskou
-
Mr Alexander Evtushenko
-
Dr Adrian Ionescu
I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, University of Cambridge, in the Thin Film Magnetism (TFM) group with Prof. Crispin Barnes on an ERC International Training Network project,...
-
Dr Aisling Redmond
Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...
-
Dr Fazlur Rahman Talukdar
I am spearheading a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive biospecimens, with the primary objective of early cancer detection and monitoring. I am a...
-
Professor Grant Stewart
Professor Stewart is an academic surgeon at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising management of patients with...
-
Dr Hayley Woffendin
After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...
-
Dr Helen Hatcher
Dr Hatcher is the Clinical and Regional lead for young people with cancer specialising in sarcomas and other rare cancers. She qualified in medicine at the University of Cambridge and has trained at the Royal Marsden Hospital in London. Her PhD and post...
-
Dr Hanna Najgebauer
Open Targets Postdoctoral Fellow responsible for the development of new algorithms and computational tools for scoring cancer in vitro models based on their clinical relevance and covered genomic heterogeneity observed in primary disease.
-
Mr Justin Davies
Justin Davies Clinical Director of Digestive Diseases and Consultant Colorectal Surgeon at Addenbrooke's Hospital, and an Associate Lecturer at the University of Cambridge. His thesis was written on molecular stool screening for colorectal cancer, and...
-
Dr Kate Fife
Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic which is one of the...
-
Dr Myriam Ouberai
I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...
-
Mr James Watson
-
Mrs Sarah Fesco
-
Dr David Fairen-Jimenez
Our research concerns the study of the molecular mechanisms that control adsorption processes in porous materials. We are particularly interested in drug delivery systems, where nanotechnology has a fundamental impact to revolutionise cancer diagnosis...
-
Miss Jamie McGinn
Project title: Epithelial cell dynamics during postnatal growth; relevance for ...
-
Dr Ali Amin Al Olama
... at highest risk of developing prostate cancer could be useful for prevention and screening programs. ...
-
Mr Arqum Anwar
... the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass spectrometry. The ...
-
Dr Andreas Bender
Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...
-
Dr Alejandra Bruna
... An integrated bioinformatic analysis found this signature to be a prognostic pathway signature in ER-/basal human breast cancer. We are now ...
-
Dr Catherine Lindon
My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...
-
Professor Adrian Liston
We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our approach is to identify key unknowns...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...
-
Dr Ashray Gunjur
I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...
-
Dr Adrien Hallou
Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a...
-
Dr Ahsan MEMON
Ahsan has developed a sui generis versatile holographic system capable of diverse photo-perturbation techniques including photo-manipulation, photo-activation, photo-ablation, optical-trapping and optogenetics, combined with multi-modal imaging...
-
Professor Sir Bruce Ponder
... enriched for genes associated with the 72 GWAS loci formally confirmed at the time of our analysis. These regulons and their TFs show ...
